Diagnóstico de síndromes parkinsonianas em uma clínica brasileira de distúrbios do movimento
DOI:
https://doi.org/10.34024/rnc.2005.v13.8789Palavras-chave:
Doença de Parkinson, Doença de Parkinson Secundária, Epidemiologia, DiagnósticoResumo
Introdução: Nosso trabalho visou observar a freqüência das etiologias na população de pacientes com síndrome parkinsoniana (SP). Casuística e método: Foram analisados retrospectivamente prontuários de pacientes com SP atendidos no Hospital das Clínicas da Universidade Estadual de Campinas entre Janeiro de 1999 e Dezembro de 2001, avaliando-se quadro clínico e exames neuroimagem. Resultados: Dos 177 prontuários analisados, 151 (85,3%) apresentavam diagnóstico de doença de Parkinson (DP), 6 (3,4%) parkinsonismo vascular (PV), 7 (4,0%) parkinsonismo induzido por drogas (PID), 6 (3,4%) Parkinson-plus (PP), 1 (0,6%) deficiência de pantetonato-quinase, 1 (0,6%) ataxia espinocerebelar forma 3, e 5 (2,8%) SP indeterminada (PI). A idade de início da doença foi de 54 ± 12 anos na DP, 75 ± 9 no PID, 60 ± 14 no PV e 53 ± 9 no PP. Conclusão: A DP foi a forma de SP mais comum em nosso ambulatório, seguido por PID, PV e PP. Os pacientes com PID tiveram idade de início significativamente maior em relação à DP.
Métricas
Referências
Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;89:242-251.
Elbaz A, Bower JH, Maraganore DM, et al. Risk tables for Parkinsonism and Parkinson’s disease. J Clin Epidemiol 2002;55:25-31.
Marsden CD. Parkinson’s disease. J Neurol Neurosurg Psychiatry 1994;57:672-681.
Cardoso F, Camargos ST, Júnior GAS. Etiology of Parkinsonism in a Brazilian movement disorders clinic. Arq Neuropsiquiatr 1998;56(2):171-175.
Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men. Neurology 2000;55:1358-1363.
Hurtig HI. Vascular parkinsonism, in Stern MB, Koller WC (eds). Parkinsonian Syndromes. New York: Marcel Dekker, 1993, 81-83.
Critchley M. Arteriosclerotic parkinsonism. Brain 1929;52:23-83.
Bennet DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger’sdisease. J Neurol Neurosurg Psychiatry 1990;53:961-965.
Trenkwalder C, Schwars J, Gebhard J, et al. Stanberg trial on epidemiology of parkinsonism and hypertension in the elderly: Prevalence of Parkinson’s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995;52:1017-1022.
Fahn S. Secondary parkinsonism. In Goldensohn and Appel (eds): Scientific Approaches to Clinical Neurology. Philadelphia: Lee & Febiger, 1977, 1159.
Melcon MO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinson’s disease in Junín, Buenos Aires Province, Argentina. Movement Disorders 1997;12(2):197-205.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17(5):S11-S26.
Gomes MM. Epidemiologia da doença de Parkinson. Arq Bras Med 1995;69(1):19-22.
Chen RC, Chang SF, Su CL, et al. Prevalence, incidence, and mortality of PD: A door-to-door survey in Ilan County, Taiwan. Neurology 2001;57:1679-1686.
de Rijk MC, Tzourio C, Breteler MMB, et al. Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatr 1997;62:10-15.
Sutcliffe RLG, Meara JR. Parkinson’s disease epidemiology in the Northampton District, England, 1992. Acta Neurol Scand 1995;92:443-450.
Ferraz, HB, Andrade LAF, Tumas V, Calia LC, Borges V. Rural or urban living and Parkinson’s Disease. Arq Neuropsiquiatr 1996;54(1):37-41.
Sugita M, Izuno T, Tatemichi M, Otahara Y. Metaanalysis for epidemiologic studies on the relationship between smoking an Parkinson’s disease. J Epidemiol 2001;11:87-94.
Teräväinen H, Forgach L, Hietanen M, Schulzer M, Schoenberg B, Calne DB. The age of onset of Parkinson’s disease: etiological implications. J Canad Scienc Neurol 1986;13(4):317-319.
Poewe WH, Wenning GK. The natural history of Parkinson’s disease. Ann Neurol 1998;44(Suppl 1):S1-S9.
